AMODIAQUINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for amodiaquine hydrochloride and what is the scope of patent protection?
Amodiaquine hydrochloride
is the generic ingredient in one branded drug marketed by Parke Davis and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for amodiaquine hydrochloride.
Summary for AMODIAQUINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 228 |
Clinical Trials: | 131 |
Patent Applications: | 4,750 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMODIAQUINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for AMODIAQUINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Swedish Research Council | Phase 2/Phase 3 |
Muhimbili University of Health and Allied Sciences | Phase 2/Phase 3 |
Uppsala University | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for AMODIAQUINE HYDROCHLORIDE
US Patents and Regulatory Information for AMODIAQUINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | CAMOQUIN HYDROCHLORIDE | amodiaquine hydrochloride | TABLET;ORAL | 006441-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |